Nikolic B, Sykes M
BMT Section, Massachusetts General Hospital/Harvard Medical School, Boston 02129, USA.
Immunol Res. 1997;16(3):217-28. doi: 10.1007/BF02786391.
Durable transplantation tolerance can be reliably achieved by inducing engraftment of hematopoietic cells in recipients initially depleted of T-lymphocytes. Engraftment of donor pluripotent hematopoietic stem cells (PPHSC) produces mixed hematopoietic chimeras in which both host and donor cells coexist and are tolerant of each other. The major mechanism of tolerance in these chimeras is central, intrathymic clonal deletion, which is induced and maintained by immigration of both host and donor marrow-derived cells to the host thymus, ensuring the ongoing central deletion of donor- and host-reactive cells. In this article, approaches developed in our laboratory to induce stable mixed hematopoietic chimerism and specific central deletional allogeneic and xenogeneic tolerance without toxic or myeloablative host conditioning are reviewed.
通过在最初清除T淋巴细胞的受体中诱导造血细胞植入,可可靠地实现持久的移植耐受性。供体多能造血干细胞(PPHSC)的植入产生混合造血嵌合体,其中宿主和供体细胞共存且相互耐受。这些嵌合体中耐受性的主要机制是中枢性胸腺内克隆清除,这是由宿主和供体骨髓来源的细胞迁移到宿主胸腺诱导并维持的,确保持续中枢清除供体反应性和宿主反应性细胞。本文综述了我们实验室开发的在无毒性或骨髓清除性宿主预处理的情况下诱导稳定混合造血嵌合以及特异性中枢性删除同种异体和异种耐受性的方法。